Michael Bogenschutz MD
Addiction
Professor, Psychiatry, University of New Mexico School of Medicine
Join to View Full Profile
1 Park AveFl 8New York, NY 10016
Dr. Bogenschutz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cambridge Health AllianceResidency, Psychiatry, 1991 - 1994- Cambridge Health AllianceInternship, Transitional Year, 1990 - 1991
Harvard Medical SchoolClass of 1990
Certifications & Licensure
NY State Medical License 2015 - 2026
NM State Medical License 1994 - 2016
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- 12-step Facilitation for the Dually Diagnosed Start of enrollment: 2005 Sep 01
- Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label Study (SAFADIE) Start of enrollment: 2006 Dec 01
- Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsThe Prognostic Role of DSM-5 Alcohol Use Disorder Severity and Age of Onset in Treatment Outcome Among Adults Aged 60.Silke Behrendt, Alexis Kuerbis, Anna Mejldal, Barbara Braun-Michl, Randi Bilberg
Journal of Addiction Medicine. 2021-05-23 - 4 citationsStability of Posttreatment Reductions in World Health Organization (WHO) Drinking Risk Levels and Posttreatment Functioning in Older Adults with DSM-5 Alcohol Use Diso...Anna Mejldal, Kjeld Andersen, Silke Behrendt, Randi Bilberg, Michael P. Bogenschutz
Alcoholism, Clinical and Experimental Research. 2021-01-26 - 1 citationsImpact of comorbid mental disorders on outcomes of brief outpatient treatment for DSM-5 alcohol use disorder in older adults.Silke Behrendt, Alexis Kuerbis, Randi Bilberg, Barbara Braun-Michl, Anna Mejldal
Journal of Substance Abuse Treatment. 2020-10-05
Press Mentions
NYU Is Launching a Center for Psychedelic MedicineMarch 7th, 2021
NYU to Develop ‘One-of-a-kind’ Psychedelic Medicine CentreFebruary 25th, 2021- NYU Langone Creates Center for Psychedelic MedicineFebruary 24th, 2021
- Join now to see all
Grant Support
- Clinical Trials Network: Southwest NodeNational Institute On Drug Abuse2010–2012
- A Program Of Research And Mentorship On Alcoholism And Co-Occuring DisordersNational Institute On Alcohol Abuse And Alcoholism2007–2011
- Clinical Trial Network: Southwest NodeNational Institute On Drug Abuse2007–2010
- 12-Step Facilitation For The Dually DiagnosedNational Institute On Alcohol Abuse And Alcoholism2005–2009
- Clinical Trials Network: New Mexico NodeNational Institute On Drug Abuse2005–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
